Funds holding Prime Medicine Inc
ISIN US74168J1016 · United States
- Fund holders
- 146
- Of which ETFs
- 33 113 other funds
- Value held
- 104.3M $
- Share of capital
- 15.9 % of 181.4M shares on Jul 31, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| SA Multi-Managed Small Cap Portfolio SEASONS SERIES TRUST | 7,992 | 27.8K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| VIP Extended Market Index Portfolio Variable Insurance Products Fund II | 7,038 | 24.5K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SIMT Small Cap Fund SEI INSTITUTIONAL MANAGED TRUST | 6,980 | 24.3K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Strategic Equity Allocation Trust John Hancock Variable Insurance Trust | 6,920 | 24.1K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Voya VACS Index Series SC Portfolio Voya VARIABLE PORTFOLIOS INC | 6,518 | 22.7K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Venerable Small Cap Index Fund Venerable Variable Insurance Trust | 6,345 | 22.1K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ProShares Ultra Russell2000 ProShares Trust | 6,160 | 28.5K $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| ProShares UltraPro Russell2000 ProShares Trust | 6,138 | 28.4K $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Columbia Integrated Small Cap Growth Fund Columbia Funds Series Trust II | 5,595 | 25.8K $ | 0.09 % | 0.00 % | as of Feb 28, 2026 ↗ |
| U.S. Small Cap Equity Fund RUSSELL INVESTMENT FUNDS | 5,423 | 18.9K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Morgan Stanley Pathway Small-Mid Cap Equity ETF MORGAN STANLEY PATHWAY FUNDS | 4,780 | 22.1K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Small-Cap Equity Portfolio PACIFIC SELECT FUND | 4,702 | 16.4K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds | 4,700 | 16.4K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ProShares Russell 2000 High Income ETF ProShares Trust | 4,311 | 19.9K $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Eventide Small Cap ETF Strategy Shares | 3,471 | 12.3K $ | 0.05 % | 0.00 % | as of Apr 30, 2026 ↗ |
| iShares Morningstar Small-Cap ETF iShares Trust | 3,379 | 12K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Nationwide Fundamental All Cap Equity Portfolio Nationwide Mutual Funds | 3,321 | 11.8K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| SmallCap Value Fund II Principal Funds, Inc | 3,320 | 11.8K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Dimensional US Core Equity 1 ETF Dimensional ETF Trust | 3,143 | 11.1K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Total Stock Market Index Trust John Hancock Variable Insurance Trust | 2,999 | 10.4K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SA U.S. Small Company Fund SA FUNDS INVESTMENT TRUST | 2,888 | 10.1K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| iShares Total U.S. Stock Market Index Fund BlackRock Funds | 2,694 | 9.6K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| EQ/Franklin Small Cap Value Managed Volatility Portfolio EQ Advisors Trust | 2,689 | 9.4K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| State Street(R) SPDR(R) Portfolio MSCI Global Stock Market ETF SPDR INDEX SHARES FUNDS | 2,645 | 9.2K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| VIP Total Market Index Portfolio Variable Insurance Products Fund II | 2,617 | 9.1K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Destinations Small-Mid Cap Equity Fund Brinker Capital Destinations Trust | 2,350 | 10.9K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| State Street Total Return V.I.S. Fund STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 2,212 | 7.7K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Dimensional U.S. Equity Market ETF Dimensional ETF Trust | 2,164 | 7.7K $ | 0.00 % | as of Apr 30, 2026 ↗ | |
| T. Rowe Price Moderate Allocation Portfolio T. ROWE PRICE EQUITY SERIES, INC. | 1,754 | 6.1K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Penn Series Small Cap Index Fund Penn Series Funds Inc | 1,500 | 5.2K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ULTRA SMALL CAP PROFUND ProFunds | 1,162 | 4.1K $ | 0.01 % | 0.00 % | as of Apr 30, 2026 ↗ |
| TIAA Separate Account VA-1 - Stock Index Account TIAA Separate Account VA-1 | 1,074 | 3.7K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Nuveen Life Stock Index Fund TIAA-CREF Life Funds | 667 | 2.3K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| State Street Balanced Index Fund STATE STREET INSTITUTIONAL INVESTMENT TRUST | 645 | 2.2K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Knights of Columbus U.S. ALL CAP INDEX FUND ADVISORS' INNER CIRCLE III | 554 | 2K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Russell 2000 2x Strategy Fund Rydex Dynamic Funds | 494 | 1.7K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| PROFUND VP ULTRA SMALL CAP ProFunds | 344 | 1.2K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| U.S. MICRO CAP PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 301 | 1.1K $ | 0.00 % | as of Apr 30, 2026 ↗ | |
| PROFUND VP SMALL CAP ProFunds | 260 | 904.8 $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Russell 2000 Fund Rydex Series Funds | 227 | 790 $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SMALL-CAP PROFUND ProFunds | 187 | 662.9 $ | 0.01 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Russell 2000 1.5x Strategy Fund Rydex Series Funds | 136 | 473.3 $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ProShares Hedge Replication ETF ProShares Trust | 102 | 471.2 $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Columbia Research Enhanced Small Cap ETF Columbia ETF Trust I | 92 | 320.2 $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ProShares Russell 2000 Dynamic Buffer ETF ProShares Trust | 30 | 138.6 $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Russell 2000(R) 1.5x Strategy Fund Rydex Variable Trust | 16 | 55.7 $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| ARK Genomic Revolution ETF ARK ETF Trust | 1.41 % | as of Apr 30, 2026 ↗ |
| AXS Green Alpha ETF INVESTMENT MANAGERS SERIES TRUST II | 1.14 % | as of Mar 31, 2026 ↗ |
| Jacob Discovery Fund Jacob Funds Inc. | 1.13 % | as of Feb 28, 2026 ↗ |
| Virtus Biotech Clinical Trials Etf ETFis Series Trust I | 0.64 % | as of Apr 30, 2026 ↗ |
| Global X Genomics & Biotechnology ETF GLOBAL X FUNDS | 0.36 % | as of Feb 28, 2026 ↗ |
| Ultra-Small Company Market Fund Bridgeway Funds, Inc. | 0.34 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Health Care ETF T. Rowe Price Exchange-Traded Funds, Inc. | 0.32 % | as of Mar 31, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST | 0.19 % | as of Mar 31, 2026 ↗ |
| PROFUND VP BIOTECHNOLOGY ProFunds | 0.18 % | as of Mar 31, 2026 ↗ |
| Direxion Daily S&P Biotech Bull 3X Shares Direxion Shares ETF Trust | 0.16 % | as of Apr 30, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 146 | +12 | 28,885,788 | +6.2 % |
| 2026Q1 | 134 | +24 | 27,195,732 | +20.5 % |
| 2025Q4 | 110 | +10 | 22,573,543 | +25.3 % |
| 2025Q3 | 100 | -4 | 18,010,900 | +22.4 % |
| 2025Q2 | 104 | -3 | 14,712,156 | -15.1 % |
| 2025Q1 | 107 | -6 | 17,325,275 | -9.6 % |
| 2024Q4 | 113 | -13 | 19,174,438 | -2.0 % |
| 2024Q3 | 126 | +7 | 19,569,526 | +1.9 % |
| 2024Q2 | 119 | +18 | 19,198,853 | +56.5 % |
| 2024Q1 | 101 | +2 | 12,270,403 | +2.6 % |
| 2023Q4 | 99 | 11,963,973 |
Institutional managers
183 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| Alphabet Inc. | 16,562,498 | 57.6M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 8,501,708 | 29.6M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 6,345,125 | 22.1M $ | as of Mar 31, 2026 |
| ARK Investment Management LLC | 6,246,827 | 21.7M $ | as of Mar 31, 2026 |
| T. Rowe Price Investment Management, Inc. | 5,481,893 | 19.1K $ | as of Mar 31, 2026 |
| Balyasny Asset Management L.P. | 4,123,365 | 14.3M $ | as of Mar 31, 2026 |
| Casdin Capital, LLC | 3,167,175 | 11M $ | as of Mar 31, 2026 |
| Woodline Partners LP | 3,003,313 | 10.5M $ | as of Mar 31, 2026 |
| Sumitomo Mitsui Trust Group, Inc. | 2,940,793 | 10.2M $ | as of Mar 31, 2026 |
| Amova Asset Management Americas, Inc. | 2,940,793 | 10.2M $ | as of Mar 31, 2026 |
| UBS Group AG | 2,888,418 | 10.1M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 2,743,700 | 9.6M $ | as of Mar 31, 2026 |
| ADAR1 Capital Management, LLC | 1,973,282 | 6.9M $ | as of Mar 31, 2026 |
| FMR LLC | 1,769,476 | 6.2M $ | as of Mar 31, 2026 |
| Redmile Group, LLC | 1,590,832 | 5.5M $ | as of Mar 31, 2026 |
| TWO SIGMA INVESTMENTS, LP | 1,572,811 | 5.5M $ | as of Mar 31, 2026 |
| D. E. Shaw & Co., Inc. | 1,393,621 | 4.8M $ | as of Mar 31, 2026 |
| FARALLON CAPITAL MANAGEMENT LLC | 1,240,843 | 4.3M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 970,425 | 3.4M $ | as of Mar 31, 2026 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 917,212 | 3.2M $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 886,716 | 3.1M $ | as of Mar 31, 2026 |
| JPMORGAN CHASE & CO | 844,154 | 2.7M $ | as of Mar 31, 2026 |
| Greenwich Wealth Management LLC | 750,001 | 2.6K $ | as of Mar 31, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | 741,039 | 2.6M $ | as of Mar 31, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 715,829 | 2.5M $ | as of Mar 31, 2026 |
Cite this page
Titelia. "Funds holding Prime Medicine Inc". https://titelia.com/en/stocks/prime-medicine-inc-US74168J1016